Infant Bacterial Therapeutics AB logo

IBT B - Infant Bacterial Therapeutics AB News Story

SEK96.4 -3.6  -3.6%

Last Trade - 12:42pm

Sector
Healthcare
Size
Small Cap
Market Cap £96.0m
Enterprise Value £59.8m
Revenue £n/a
Position in Universe 917th / 1829

BRIEF-Infant Bacterial Therapeutics Operating Loss Narrows To SEK 26.7 Mln

Fri 5th February, 2021 7:10am
Feb 5 (Reuters) - Infant Bacterial Therapeutics AB
 IBTb.ST :
    * REG-INFANT BACTERIAL THERAPEUTICS AB (PUBL) INTERIM
MANAGEMENT
STATEMENT, JANUARY 1 – DECEMBER 31, 2020
    * Q4 OPERATING LOSS SEK 26.7 MILLION VERSUS LOSS SEK 27.4
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNEbYsG4l 
Further company coverage:  IBTb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.